Utility of growth differentiation factor-15 as a predictor of cardiovascular surgery outcomes: Current research and future directions

This study acknowledges that the relationship between patient outcomes and elevated GDF-15 levels is not limited to CVDs or cardiac surgery but can be associated with variable diseases, including diabetes and cancer. Moreover, the normal range of GDF-15 is not well defined. Given its promise for improving patient care and outcomes in cardiovascular surgery, future research should explore the potential of GDF-15 as a biomarker for postoperative outcomes and target therapeutic intervention.PMID:37648079 | DOI:10.1016/j.jjcc.2023.08.013

Source: Journal of Cardiology - August 30, 2023 Category: Cardiology Authors: Ikuko Shibasaki Naoyuki Otani Motoshi Ouchi Taira Fukuda Taiki Matsuoka Shotaro Hirota Shohei Yokoyama Yuta Kanazawa Takashi Kato Riha Shimizu Masahiro Tezuka Yusuke Takei Go Tsuchiya Shunsuke Saito Taisuke Konishi Koji Ogata Shigeru Toyoda Hirotsugu Fuku Source Type: research